Back

Efficacy of long lasting therapy with ramipril and eprosartan on diastolic dysfunction, functional class of HFpEF and insulin resistance in hypertensives

20 April 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Heart failure Chronic Heart Failure, Other EAPC Premium Access EuroPrevent 2018

About the speaker

Photo
Doctor Nadejda Sapojnic

Gheorghe Paladi Clinical Municipality Hospital, Chisinau (Moldova (Republic of))

10 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Presentation thumbnail
Associate Professor Y. Shaposhnikova (Kharkiv, UA)
Presentation thumbnail
Doctor C. Mantis (Athens, GR)
Abstract
Presentation thumbnail

Access the full session

Session thumbnail
Poster Session 2 - Heart failure

The Event

Event poster

EuroPrevent 2018

20 April 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Sequential nephron blockade with diuretics improves diastolic dysfunction in patients with resistant hypertension, a substudy a the PHARES trial
1 September 2019
thumbnail
Webinar
Unmet needs in HF: patients with LVEF equal or above 40%
12 December 2024
thumbnail
Congress Presentation
Mutual effect modification between insulin-resistance and endothelial dysfunction in predicting incident heart failure in hypertensives
26 August 2023
thumbnail
Congress Presentation
Impact of diabetes mellitus on long-term clinical outcomes in patients with moderate diastolic dysfunction and preserved ejection fraction
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources